FDA Approves Prior Approval Supplement for BIVIGAM®

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. TLT
9. PMTS
10. QQQ

Go back to FDA Approves Prior Approval Supplement for BIVIGAM®
ADMA Biologics Inc Com (NASDAQ: ADMA) Delayed: 9.30 -0.09 (0.96%)
Previous Close $9.39    52 Week High $9.65 
Open $9.44    52 Week Low $4.15 
Day High $9.50    P/E N/A 
Day Low $9.20    EPS $-0.01 
Volume 786,475